ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Revenue, 2025
- $199.1B
- YoY, 2025
- +12.5%
- 5-year CAGR
- +10.3%
- 10-year CAGR
- +9.7%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $199.1B | +12.5% |
| 2024 | $177.0B | +3.3% |
| 2023 | $171.3B | +9.4% |
| 2022 | $156.6B | +13.0% |
| 2021 | $138.6B | +13.8% |
| 2020 | $121.9B | +16.9% |
| 2019 | $104.2B | +13.1% |
| 2018 | $92.1B | +2.3% |
| 2017 | $90.0B | +6.1% |
| 2016 | $84.9B | +7.2% |
| 2015 | $79.2B | +7.2% |
| 2014 | $73.9B | +4.0% |
| 2013 | $71.0B | +15.5% |
| 2012 | $61.5B | +1.3% |
| 2011 | $60.7B | +3.4% |
| 2010 | $58.7B | −9.6% |
| 2009 | $64.9B | +6.0% |
| 2008 | $61.3B | +0.1% |
| 2007 | $61.2B | — |